Sekhmet Pharmaventures Private Limited

Sekhmet Pharmaventures Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74999MH2020PTC340954 Incorporated 23 June 2020 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1,064.13 Cr
▲ 1% YoY
Net loss · FY 2025
₹233.93 Cr
Net margin -22%
EBITDA · FY 2025
-₹16.71 Cr
EBITDA margin -1.6%
Authorised capital
₹3,250 Cr
Registered with MCA
Paid-up capital
₹2,062.82 Cr
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
12
Provident fund records
Directors on board
6
As per MCA filings

About Sekhmet Pharmaventures Private Limited

Data last updated:

Sekhmet Pharmaventures Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Gamot Api Pte. Ltd. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 23 June 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2020PTC340954. Its GSTIN is 27ABDCS8226R1ZK (Maharashtra).

The company has an authorised share capital of ₹3,250 Cr and a paid-up capital of ₹2,062.82 Cr. It was formerly known as Stepahead Business Services Private Limited. It is led by directors including Santosh Kumar Mahil (Managing Director) and Mukesh Kumar Sitaram Agarwal (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹1,064.13 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net loss of ₹233.93 Cr (net margin -22%) and EBITDA of -₹16.71 Cr (EBITDA margin -1.6%). Revenue has grown at a compounded annual rate (CAGR) of 78% over three years.

The company has about 12 employees on its provident fund (EPFO) records. Its group structure includes 4 subsidiaries.

The company is associated with 1 brand: Sekhmet Pharmaventures. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 2 cases are pending. The company has 7 deals on record (3 secondary share transfers, 2 funding rounds, 1 convertible or debt financing), with disclosed funding of ₹759.72 Cr; the latest was in June 2024.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sekhmetpharma.com.

Company details

CIN U74999MH2020PTC340954
Registration Number 340954
Incorporation Date 23 June 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 December 2025
Date of Balance Sheet 31 March 2025
Parent Company Gamot Api Pte. Ltd
Compliance Status Active Compliant

Contact details

Sekhmet Pharmaventures Private Limited's registered office is in Mumbai, Maharashtra. Its website is sekhmetpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Unit No. 220 C – Wing 2nd Floor 215 Atrium Cts, Andheri Kurla Road Andheri East, Mumbai, Maharashtra, India – 400059
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Sekhmet Pharmaventures Private Limited, buy the company report.

Comprehensive company report
Sekhmet Pharmaventures Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Sekhmet Pharmaventures operates one associated brand: Sekhmet Pharmaventures. Each brand links to its own profile.

BrandDescriptionWebsite
Stakes in fast-growing Indian pharma companies are acquired and developed.sekhmetpharma.com

Business activity

The main business activity of Sekhmet Pharmaventures is professional, scientific and technical. In detail, this covers management consultancy activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM3Management consultancy activities

To see the full business activity and turnover split of Sekhmet Pharmaventures Private Limited, buy the company report.

Financials of Sekhmet Pharmaventures Private Limited

FY 2025 filings available

Sekhmet Pharmaventures Private Limited reported revenue of ₹1,064.13 Cr (up 1% YoY) for FY 2025.

Revenue · FY 2025
₹1,064.13 Cr ▲ 1%
Net loss · FY 2025
₹233.93 Cr margin -22%
EBITDA · FY 2025
-₹16.71 Cr margin -1.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 78%
EBITDA CAGR growth
1 year
▼ 114%
3 years · compounded
▼ 35%

Revenue has grown at a compounded annual rate (CAGR) of 78% over three years, including 1% growth in the latest year. EBITDA fell 114% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹16.71 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹233.93 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-1.6%
Net Profit Margin-22%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sekhmet Pharmaventures Private Limited, buy the company report.

Board of directors of Sekhmet Pharmaventures Private Limited

Sekhmet Pharmaventures has 6 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Aswin VikramDirector28 Oct 20224 Years 0 MonthsCurrent
Anchit GuptaDirector04 Dec 20205 Years 11 MonthsCurrent
Vivek ChhachhiDirector04 Dec 20205 Years 11 MonthsCurrent
Nikhil Kumar SrivastavaDirector03 Oct 20206 Years 1 MonthsCurrent
Santosh Kumar MahilManaging Director03 Jun 20251 Years 5 MonthsCurrent
Mukesh Kumar Sitaram AgarwalWhole-Time Director18 Mar 20260 Years 7 MonthsCurrent

Auditor

Sekhmet Pharmaventures Private Limited is audited by B S R & Co. LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
B S R & Co. LLPFY 2023101248W/W-100022

Shareholding

The shareholding of Sekhmet Pharmaventures Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sekhmet Pharmaventures Private Limited, buy the company report.

Deals & funding

Sekhmet Pharmaventures Private Limited has 7 deals on record (3 secondary share transfers, 2 funding rounds, 1 convertible or debt financing), with disclosed funding of ₹759.72 Cr; the latest was in June 2024.

Total deals
7
Secondary share transfers
3
Funding rounds
2
Convertible or debt financing
1
Acquisition
1
Disclosed funding
₹759.72 Cr

To see the full deal history of Sekhmet Pharmaventures Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sekhmet Pharmaventures Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Sekhmet Pharmaventures has 4 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

4
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Optimus Life Science Private LimitedU24110TG2020PTC139669
Anjan Drug Private LimitedU24231TN1990PTC019461
Optimus Drugs Private LimitedU24239TG2003PTC042155
Optimus Pharma Private LimitedU24239TG2004PTC044232

To see the full group structure of Sekhmet Pharmaventures Private Limited, buy the company report.

Employees & EPFO

Sekhmet Pharmaventures Private Limited has a workforce of 12 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.

Employee count
12
Active EPFO establishments
1
Employee growth
50%

GST

Sekhmet Pharmaventures has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27ABDCS8226R1ZKMaharashtraActive11 Aug 2020

To see the full GST registrations and return filing status of Sekhmet Pharmaventures Private Limited, buy the company report.

Recent activity

Sekhmet Pharmaventures Private Limited has 26 board changes on record since 2020: 16 appointments and 10 cessations. The latest: Mukesh Kumar Sitaram Agarwal was appointed as Whole-Time Director on 18 Mar 2026.

Appointed
Mukesh Kumar Sitaram Agarwal was appointed as Whole-Time Director.
AGM
Sekhmet Pharmaventures Private Limited last Annual general meeting of members was held on 30 Dec 2025 as per latest MCA records.
Ceased
Lakshay Kataria ceased to be Whole-Time Director.
Appointed
Santosh Kumar Mahil was appointed as Managing Director.
Ceased
Anil Khubchandani ceased to be CEO.
Appointed
Lakshay Kataria was appointed as Whole-Time Director.
Filing
Sekhmet Pharmaventures Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Srinivasareddy Desireddy ceased to be Director.
Ceased
Ashwin Savio Trinidad ceased to be Company Secretary.
Appointed
Anil Khubchandani was appointed as CEO.
Ceased
Annaswamy Vaidheesh ceased to be Director.
Appointed
Aswin Vikram was appointed as Director.

17 earlier events are in the company report.

Frequently asked questions

Sekhmet Pharmaventures is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 23 June 2020 (6+ years old) and is registered under CIN U74999MH2020PTC340954.

Sekhmet Pharmaventures has 6 current directors:

The latest financial statements of Sekhmet Pharmaventures on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 December 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Sekhmet Pharmaventures is 27ABDCS8226R1ZK, registered in Maharashtra.

The CIN (Corporate Identification Number) of Sekhmet Pharmaventures is U74999MH2020PTC340954. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sekhmet Pharmaventures has 3 court cases on record: 1 filed by the company and 2 filed against it. 2 are pending. Most are in the high courts.

Sekhmet Pharmaventures was incorporated on 23 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.

Sekhmet Pharmaventures has 7 deals on record (3 secondary share transfers, 2 funding rounds, 1 convertible or debt financing), with disclosed funding of ₹759.72 Cr; the latest was in June 2024.

Mukesh Kumar Sitaram Agarwal was appointed as Whole-Time Director on 18 Mar 2026. Lakshay Kataria ceased to be Whole-Time Director on 26 Jun 2025. Santosh Kumar Mahil was appointed as Managing Director on 03 Jun 2025. Sekhmet Pharmaventures has 26 board changes on record in total.

Sekhmet Pharmaventures can be reached through the website sekhmetpharma.com. Its registered office is in Mumbai, Maharashtra, India.